Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool

16d ago

SCLX

PremiumThe Fly

Scilex announces U.S. Bankruptcy Court extends lockup period on shares

29d ago

SCLX

PremiumPress Releases

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend

29d ago

SCLX

PremiumCompany Announcements

Scilex Holding Ends Equity Purchase Deal with Yorkville

1M ago

SCLX

PremiumThe Fly

Scilex announces new out-of-pocket costs for commercially insured patients

1M ago

SCLX

PremiumPress Releases

Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients

1M ago

SCLX

PremiumThe FlyScilex seeks approval from FDA for modification of Gloperba label

1M ago

SCLX

PremiumPress Releases

Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed

1M ago

SCLX

PremiumThe Fly

Scilex announces agreement with Takeda to resolve patent infringement lawsuit

1M ago

TAK

SCLX

PremiumPress Releases

Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®

1M ago

SCLX

PremiumThe Fly

Scilex announces repayment of balance of convertible debentures

1M ago

ORMP

SCLX

PremiumThe Fly

Scilex provides responses to product composition questions related to ELYXYB

1M ago

SCLX

PremiumPress Releases

Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.

1M ago

SCLX

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement

PremiumPress ReleasesScilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement

1M ago

SCLX

PremiumThe Fly

Scilex enters release, settlement agreement with Virpax Pharmaceuticals

1M ago

SCLX

VRPX

PremiumCompany Announcements

Riding the Biotech Rollercoaster: Scilex’s Stock Volatility Amid Sector Uncertainty

1M ago

SCLX

SCLX Stock Latest News

Trending

Indices

Stocks

ETFs